News

ISTAT. In April industrial production of pharmaceutical products +0.6%

In April 2023, the seasonally adjusted industrial production index is estimated to decrease by 1.9% compared to March. On average for the February-April period, the level of production decreased by 1.3% compared to the previous three months.

The seasonally adjusted monthly index marks short-term decreases in all sectors: negative changes characterize, in fact, intermediate goods (-2.6%), capital goods (-2.1%) and, to a lesser extent, consumer goods ( -0.4%) and energy (-0.3%).

Corrected for calendar effects, in April 2023 the overall index decreased in trend terms by 7.2% (calendar working days were 18 against 19 in April 2022). Tendency declines characterize all sectors; the reduction is modest for capital goods (-0.2%), while it is more significant for energy (-12.6%), intermediate goods (-11.0%) and consumer goods (-7.3%).

The only sectors of economic activity with a growth trend are the manufacture of means of transport (+5.7%), the manufacture of coke and refined petroleum products (+2.1%) and the production of basic pharmaceutical products and pharmaceutical preparations (+0.6%). The largest decreases are recorded in the wood, paper and printing industries (-17.2%), in the supply of electricity, gas, steam and air (-13.6%) and in the manufacture of chemical products and metallurgy and manufacturing of metal products (-10.9% for both sectors).


The comment

In April, for the fourth consecutive month, there was a cyclical decline in the seasonally adjusted index of industrial production, with decreases extending to all the main sectors.
The picture is also negative on a quarterly basis.

Even in trend terms, net of calendar effects, a marked fall can be observed. At the sectoral level, the decrease for energy and intermediate goods is very large, while the decrease for capital goods is limited.

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco